- Home
- CCIR vs ZBIO Comparison
CCIR vs ZBIO Comparison
Compare CCIR & ZBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCIR
- ZBIO
- Stock Information
- Founded
- CCIR 2021
- ZBIO 2019
- Country
- CCIR United States
- ZBIO United States
- Employees
- CCIR N/A
- ZBIO N/A
- Industry
- CCIR
- ZBIO
- Sector
- CCIR
- ZBIO
- Exchange
- CCIR NYSE
- ZBIO NYSE
- Market Cap
- CCIR 351.0M
- ZBIO 389.2M
- IPO Year
- CCIR 2024
- ZBIO 2024
- Fundamental
- Price
- CCIR $11.48
- ZBIO $8.43
- Analyst Decision
- CCIR
- ZBIO Strong Buy
- Analyst Count
- CCIR 0
- ZBIO 7
- Target Price
- CCIR N/A
- ZBIO $32.29
- AVG Volume (30 Days)
- CCIR 504.0K
- ZBIO 197.8K
- Earning Date
- CCIR 01-01-0001
- ZBIO 05-16-2025
- Dividend Yield
- CCIR N/A
- ZBIO N/A
- EPS Growth
- CCIR N/A
- ZBIO N/A
- EPS
- CCIR 0.16
- ZBIO N/A
- Revenue
- CCIR N/A
- ZBIO $5,000,000.00
- Revenue This Year
- CCIR N/A
- ZBIO N/A
- Revenue Next Year
- CCIR N/A
- ZBIO N/A
- P/E Ratio
- CCIR $68.46
- ZBIO N/A
- Revenue Growth
- CCIR N/A
- ZBIO N/A
- 52 Week Low
- CCIR $9.92
- ZBIO $5.83
- 52 Week High
- CCIR $12.80
- ZBIO $26.25
- Technical
- Relative Strength Index (RSI)
- CCIR N/A
- ZBIO N/A
- Support Level
- CCIR N/A
- ZBIO N/A
- Resistance Level
- CCIR N/A
- ZBIO N/A
- Average True Range (ATR)
- CCIR 0.00
- ZBIO 0.00
- MACD
- CCIR 0.00
- ZBIO 0.00
- Stochastic Oscillator
- CCIR 0.00
- ZBIO 0.00
Stock Price Comparison Chart: CCIR vs ZBIO
■ CCIR
■ ZBIO
About CCIR COHEN CIRCLE ACQUISITION CORP I
Cohen Circle Acquisition Corp I is a blank check company.
About ZBIO ZENAS BIOPHARMA INC
Zenas BioPharma Inc is a clinical-stage biopharmaceutical company. Its I&I product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcyRIIb, which are present across B cell lineage, in order to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them.
Share on Social Networks:
0